beta-thujaplicin has been researched along with Carcinoma, Embryonal in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, T | 1 |
| Muto, N | 1 |
| Itoh, N | 1 |
| Dota, A | 1 |
| Nishina, Y | 1 |
| Inada, A | 1 |
| Tanaka, K | 1 |
1 other study available for beta-thujaplicin and Carcinoma, Embryonal
| Article | Year |
|---|---|
Induction of differentiation of embryonal carcinoma F9 cells by iron chelators.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Embryonal; Cations; Cell Differentiation; Iron Chelatin | 1995 |